Enginuity Rx

health AI / digital health / medtech / pharma digital marketing

Visit website LinkedIn ↗

StageSeed

Raised$974,999

Founded2024

Employees4

LocationWayne, PA

Business modelB2B2C / SaaS / fee based on prescriptions generated

About

ENGINUITY Rx is a closed system of direct-to-consumer, end-to-end digital care that acts as a new patient acquisition and retention engine with capabilities in acquisition marketing, telehealth, mail order pharmacy and first party data management. Unlike simply putting a "talk to a doctor now" button on a brand.com page, hoping people use it, and being disappointed with the results, our full funnel first party patient data fuels continuous improvement in conversion and efficiency. Unlike fee for service companies with no skin in the performance of a brand, ENGINUITY Rx funds acquisition media in return for a share of net sales on units through our channel. Fee for performance. No financial risk for our pharma partners. Is your brand a good fit for our channel? Let's find out.

Product

Value proposition: Closed system of D2C end-to-end digital care for new patient acquisition of pharma brands’ Rx, with first-party data management and reimbursement optimization.
Target customers: Pharmaceutical brands seeking branded medicines and patient acquisition partners
Pricing: commission-based / per-prescription revenue sharing (funding acquisition costs, compensation based on prescriptions generated)

Founders

Peter Miller — Co-founder, Chairman, and CEO
Lance Tyler — Co-founder, President, and COO

Products

closed loop data platform for patient acquisitiontelehealth accesspharmacist-enabled mail-order pharmacyfirst-party data management and analytics

Key features

end-to-end digital care for new patient acquisitionfirst-party data capture at each funnel stageclosed ecosystem integrating online behaviors, medical consultations, prescription fulfillment, and feedbackPAs and reimbursement managementfund acquisition costs with compensation tied to prescriptions generatedprospective reach to new and lapsed users outside traditional direct-selling

Technologies

closed loop data systemdata integration platformtelemedicinedigital marketing / attribution

Integrations

EHRs / platforms / systems

Care settings

telehealthmail-order pharmacyvirtual care

Traction metrics

drives incremental Rx demandclosed loop system improves patient acquisition and lifetime value

Investors

FS Investors

News

Former Optinose CEO Peter Miller comes out of retirement to launch new startup · 2024-12-01T22:44:00.000Z
Enginuity Rx launches XHANCE with Optinose through e-commerce. · 2025-03-05T00:00:00.000Z
Former Optinose CEO Peter Miller comes out of retirement to launch ... · 2024-12-02T00:00:00.000Z
Enginuity: Turning patents into innovation fuel? · 2025-03-20T09:00:00.000Z
Enginuity raises £500,000 to unlock $1.58tn in unused global innovation · 2026-02-24T13:21:10.000Z
Enginuity raises £500K investment led by Fuel Ventures - London Tech News | londonlovestech.com · 2026-02-24T11:19:09.000Z

Browse similar startups

Related startups

First Choice Benefits Inc — Southampton, PA
GoWell Benefits — Narberth, PA
HEARTio — Pittsburgh, PA
HERITAGE MILLS PERSONAL CARE CENTER — tower city, PA
HOPE SPRINGS BEHAVIORAL HEALTH INC — Jamison, PA
Krystal Vision Eye Care — Philadelphia, PA
Entirety Biomedical — Newark
Envera Health — Dallas, TX
Eonix Solution — Sheridan, WY
Episteme Prognostics, Inc. — Brooklyn, NY
Equis Consulting Group — Union City, IN
Essential Pediatrics — Newton, MA

Profile updated Jul 29, 2026. Sources: enginuityrx.com, linkedin.com